standards > terminology artifact > DOI:10.25504/FAIRsharing.a557he


ready Ontology of Cardiovascular Drug Adverse Events

Abbreviation: OCVDAE


General Information
With increased usage of cardiovascular drugs (CVDs) for treating cardiovascular diseases, it is important to analyze CVD-associated adverse events (AEs). The Ontology of Cardiovascular Drug Adverse Events (OCVDAE) is an ontology of adverse events associated with cardiovascular disease drugs. It extends the Ontology of Adverse Events (OAE) and NDF-RT. OCVDAE includes 194 CVDs, CVD ingredients, mechanisms of actions (MoAs), and CVD-associated 736 AEs.



How to cite this record FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Feb. 22, 2018, 2:10 p.m.; Last accessed: Nov 19 2018 9:56 p.m.


Record added: Oct. 24, 2017, 9:41 a.m.
Record updated: Feb. 19, 2018, 7:43 p.m. by The FAIRsharing Team.

Show edit history



Support

General

Additional Information

External Links


Tools

    No tools defined


Schemas

No XSD schemas defined


Access / Retrieve Data

Conditions of Use





Publications

Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China.

Wang L,Li M,Xie J,Cao Y,Liu H,He Y
Sci Rep 2017

View Paper (PubMed) View Publication

OCVDAE Ontology Display

View in BioPortal.


Disclaimer: This widget assumes the availability of the ontology resources in the NCBO BioPortal.


Related Standards

Reporting Guidelines

No guidelines defined

Models and Formats

No syntax standards defined

Identifier Schemas

No identifier schema standards defined


Implementing Databases (0)

No Related Databases


Implementing Policies

This record is not implemented by any policy.